SignatureFD’s iBio IBIO Stock Holding History

SignatureFD’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31	Closed	-$13K	–	2001
2018 Q3	$13K	Sell	31 -275	-90%	-$111K	﹤0.01%	1308
2018 Q2	$138K	Buy	306 +275	+887%	+$208K	0.02%	504
2018 Q1	$33K	Hold	31	–	–	﹤0.01%	883
2017 Q4	$27K	Hold	31	–	–	﹤0.01%	347
2017 Q3	$49K	Hold	31	–	–	0.01%	314
2017 Q2	$59K	Hold	31	–	–	0.01%	291
2017 Q1	$66K	Hold	31	–	–	0.01%	282
2016 Q4	$60K	Hold	31	–	–	0.01%	231
2016 Q3	$84K	Hold	31	–	–	0.01%	404
2016 Q2	$110K	Hold	31	–	–	0.02%	281
2016 Q1	$87K	Hold	31	–	–	0.01%	311
2015 Q4	$86K	Hold	31	–	–	0.02%	267
2015 Q3	$104K	Hold	31	–	–	0.02%	212
2015 Q2	$145K	Hold	31	–	–	0.03%	169
2015 Q1	$117K	Hold	31	–	–	0.03%	188
2014 Q4	$105K	Buy	+31	New	+$166K	0.03%	190

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SignatureFD's IBIO Position: Q4 2018 in Review

SignatureFD sold out of iBio (IBIO) in Q4 2018, closing a stake of 31 shares — an estimated $13K sold.

SignatureFD first reported a position in IBIO in Q4 2014 and held it in 16 quarters. The position peaked at $145K in Q2 2015. 13 funds tracked by Wall St. Rank hold IBIO as of Q4 2018.

SignatureFD reported no remaining iBio position as of Q4 2018 after selling out during the quarter.
SignatureFD sold 31 iBio shares in Q4 2018, an estimated $13K.
SignatureFD first reported a position in iBio in Q4 2014 and held it in 16 quarters.
SignatureFD's iBio position peaked at $145K in Q2 2015.
13 funds tracked by Wall St. Rank held iBio as of Q4 2018.

Based on SignatureFD's 13F filing for Q4 2018, filed 13 Feb 2019.